Physician profile
Christopher DO Elia
NPI 1386081677
$34,039.47
in general payments reported to CMS, 2019-2025
29 companies · $20K in 2025
The $20K reported for 2025 was more than what 90% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $335 · 2020: $34.95 · 2021: $2,919 · 2022: $2,051 · 2023: $7,565 · 2024: $879 · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $21K · Travel and Lodging: $4,916 · Food and Beverage: $3,283.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $20,500.00 |
| Travel and Lodging | $4,915.75 |
| Food and Beverage | $3,283.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $22,769.06 | 2021-2025 | Other - Miscellaneous, Safeop, Invictus Mis |
| Orthofix Medical, INC. | $4,907.96 | 2023-2025 | Hollywood Nanometalene, Newbridge, M6-C |
| Seaspine Orthopedics Corporation | $1,635.42 | 2021-2022 | |
| Stryker Corporation | $1,472.51 | 2021-2025 | Everest Spinal System, Yukon Oct Spinal System, Ozark Cervical Plate System |
| Globus Medical, INC. | $1,088.65 | 2021-2025 | Capitol, Acp, Coalition Agx |
| Medtronic, INC. | $440.44 | 2022-2025 | Unid_pass, Sovereign Spinal System, Kyphon Express II Kyphopak Tray |
| Medtronic USA, INC. | $286.84 | 2019 | |
| Cerapedics INC. | $204.84 | 2022-2023 | I-Factor Peptide Enhanced Bone Graft |
| Carlsmed, INC. | $169.15 | 2022 | |
| Boston Scientific Corporation | $142.82 | 2022 | |
| Depuy Synthes Sales INC. | $135.29 | 2023 | Matrixneuro |
| Si-Bone, INC. | $117.58 | 2022-2025 | |
| Abbvie INC. | $89.29 | 2021 | |
| Longeviti Neuro Solutions INC | $70.00 | 2023 | |
| Augmedics INC. | $64.82 | 2024-2025 | Xvision |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $52.81 | 2020-2021 | |
| Xtant Medical INC | $51.97 | 2024 | |
| Providence Medical Technology, INC. | $48.31 | 2022-2024 | |
| Surgalign Spine Technologies, INC. | $48.09 | 2019 | |
| Bioventus LLC | $47.80 | 2025 | Bonescalpel & Sonicone (O.R.) |
| Amgen INC. | $37.60 | 2025 | Evenity |
| Djo, LLC | $30.33 | 2023 | Cmf |
| Kuros Biosciences USA, INC | $25.62 | 2025 | Magnetos |
| Mimedx Group, INC. | $22.23 | 2025 | |
| Surgenex LLC | $19.04 | 2025 | Ardeograft, Surgraft, Surmatrix |
| Pinnacle, INC | $17.38 | 2024 | |
| Solventum Corporation | $16.27 | 2024 | Prevena |
| Spineology INC. | $14.14 | 2022 | |
| Theragen, INC. | $13.21 | 2023 | Actastim-S |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Elia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.